Proton pump inhibitor therapeutic interchange: Patient expectations and satisfaction ratings

Hospital Pharmacy

Volumn 35, Issue 11, 2000, Pages 1203-1206

  Galt, K A ^a   Galt, M A ^a   Sodorff, M M ^a   Turner, P D ^a   Lambrecht, J ^a  

^a CREIGHTON UNIVERSITY   (United States)

Author keywords

Gastrointestinal agents; Outcome and process assessment; Patient satisfaction; Proton pump inhibitors; Therapeutic interchange

Indexed keywords

LANSOPRAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; CLINICAL ARTICLE; CONTROLLED STUDY; COST CONTROL; DRUG COST; DRUG PROGRAM; DRUG USE; HOSPITAL PHARMACY; HUMAN; PATIENT ATTITUDE; PATIENT SATISFACTION; REVIEW; TREATMENT OUTCOME;

EID: 0033729742     PISSN: 00185787     EISSN: None     Source Type: Journal    
DOI: 10.1177/001857870003501119     Document Type: Review

References (14)

1. Cost minimization using market growth of a proton pump inhibitor therapeutic interchange program applied in a multihospital integrated health system
2. How to survey patient satisfaction
3. Development and validation of scales to measure patient satisfaction with health care services. Volume I, Part A: Review of the literature, overview of methods, and results regarding construction of scales
4. Obtaining information on patient satisfaction with hospital care: Mail versus telephone
5. The General Medical Health Rating: A bedside global rating of medical comorbidity in patients with dementia
6. An exploratory analysis of medication utilization in a medical intensive care unit
7. Clinical markers of asthma severity and risk: Importance of subjective as well as objective factors
8. Drugs, foods and other substances in the cause and treatment of reflux esophagitis
9. Rationale and efficacy of conservative therapy for gastroesophageal reflux disease
10. Review of moderate alcohol consumption and reduced risk of coronary heart disease: Is the effect due to beer, wine, or spirits?
11. Alcohol consumption, serum low density lipoprotein cholesterol concentration, and risk of ischaemic heart disease: Six-year follow up in the Copenhagen male study
12. A guideline for the treatment and prevention of NSAID-induced ulcers